Across TCGA pan-cancer cohorts, NBDY Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NBDY data layer compared with 22 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher NBDY Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NBDY expression acts as an unfavorable survival marker.

COAD and BRCA are the cancer types where NBDY Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.267	0.803	<.001	30	view →
BRCA	OS	Median	All	0.181	0.579	.028	4	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: NBDY tumor-vs-normal RNA expression · all NBDY data types